Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 55178 [05-18652]

Download as PDF 55178 Federal Register / Vol. 70, No. 181 / Tuesday, September 20, 2005 / Notices human environment. Thus, the NRC has determined not to prepare an environmental impact statement for the proposed action. Further Information 1. McPhee, Mark, M.D., Chief Operating Officer, Saint Luke’s Hospital of Kansas City, letter to U.S. Nuclear Regulatory Commission, December 1, 2004 (ML052510691). 2. Decommissioning Report (Final Status Survey Report), Saint Luke’s Hospital of Kansas City, Medical Plaza I Building, 4320 Wornall Road, and the Dickson-Diveley Laboratory, 4312 J.C. Nichols Parkway, Kansas City, Missouri facilities, June 21, 2005 (ML052510686). 3. Saint Luke’s Hospital of Kansas City Conversation Record, dated September 2, 2005 (ML052510698). 4. U.S. Nuclear Regulatory Commission, ‘‘Environmental Review Guidance for Licensing Actions Associated with NMSS Programs,’’ NUREG–1748, August 2003. 5. U.S. Nuclear Regulatory Commission, ‘‘Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Nuclear Facilities,’’ NUREG–1496, August 1994. 6. NRC, NUREG–1757, ‘‘Consolidated NMSS Decommissioning Guidance,’’ Volumes 1–3, September 2003. If you do not have access to ADAMS or if there are problems in accessing the documents located in ADAMS, contact the NRC Public Document Room (PDR) reference staff at (800) 397–4209, (301)415–4737 or by e-mail to pdr@nrc.gov. Documents may also be viewed electronically on the public computers located at the NRC’s PDR, O 1 F21, One White Flint North, 11555 Rockville Pike, Rockville, MD 20852. The PDR reproduction contractor will copy documents for a fee. Dated at Lisle, Illinois, this 12th day of September 2005. Jamnes L. Cameron, Chief, Decommissioning Branch, Division of Nuclear Materials Safety, RIII. [FR Doc. 05–18664 Filed 9–19–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission (NRC). ACTION: Notice of meeting. AGENCY: SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting of VerDate Aug<31>2005 14:53 Sep 19, 2005 Jkt 205001 the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 25 and 26, 2005. A sample of agenda items to be discussed during the public sessions includes: (1) Discussion of the Energy policy Act of 2005, which provides for NRC regulation of accelerator-produced radioactive material and discrete sources of Ra–226; (2) Status of Specialty Board applications for NRC recognition; (3) Electronic signature in written directives; (4) Revision of NRC Form 313A; (5) RIS on dose control and assessment; (6) Review of the medical events definition commission paper. To review the agenda, see http:// www.nrc.gov/reading-rm/doccollections/acmui/agenda/ or contact, via e-mail MSS@nrc.gov. Purpose: Discuss issues related to 10 CFR part 35, Medical Use of Byproduct Material. Date and Time for Closed Session Meeting: October 25, 2005, from 8 a.m. to 10 a.m. This session will be closed so that NRC staff can brief the ACMUI on discussing information relating solely to internal personnel rules. Dates and Times for Public Meetings: October 25, 2005, from 10 a.m. to 5 p.m.; and October 26, 2005, from 8 a.m. to 5 p.m. Address for Public Meetings: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2B3, 11545 Rockville Pike, Rockville, MD 20852–2738. FOR FURTHER INFORMATION CONTACT: Mohammad S. Saba, telephone (301) 415–7608; e-mail MSS@nrc.gov of the Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit a reproducible copy to Mohammad S. Saba, U.S. Nuclear Regulatory Commission, Mail Stop T8F03, Washington, DC 20555. Submittals must be postmarked by October 3, 2005 and must pertain to the topics on the agenda for the meeting. 2. Questions from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The transcript and written comments will be available for inspection on NRC’s Web site (http:// PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 www.nrc.gov) and at the NRC Public Document Room, 11555 Rockville Pike, Rockville, MD 20852–2738, telephone (800) 397–4209, on or about January 26, 2006. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. 4. Attendees are requested to notify Mohammad S. Saba at (301) 415–7608 of their planned attendance if special services, such as for the hearing impaired, are necessary. Dated at Rockville, Maryland, this 14th day of September, 2005. For the Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 05–18652 Filed 9–19–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Sunshine Act Meetings Weeks of September 19, 26, October 3, 10, 17, 24, 2005. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and Closed. MATTERS TO BE CONSIDERED: DATES: Week of September 19, 2005 There are no meetings scheduled for the Week of September 19, 2005. Week of September 26, 2005—Tentative There are no meetings scheduled for the Week of September 26, 2005. Week of October 3, 2005—Tentative There are no meetings scheduled for the Week of October 3, 2005. Week of October 10, 2005—Tentative There are no meetings scheduled for the Week of October 10, 2005. Week of October 17, 2005—Tentative Tuesday, October 18, 2005 9:30 a.m. Briefing on Decommissioning Activities and Status (Public Meeting) This meeting will be webcast live at the Web address—http:// www.nrc.gov. Week of October 25, 2005—Tentative Wednesday, October 26, 2005 1:30 p.m. Discussion of Security Issues (Closed—Ex. 1) E:\FR\FM\20SEN1.SGM 20SEN1

Agencies

[Federal Register Volume 70, Number 181 (Tuesday, September 20, 2005)]
[Notices]
[Page 55178]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18652]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission (NRC).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
October 25 and 26, 2005. A sample of agenda items to be discussed 
during the public sessions includes: (1) Discussion of the Energy 
policy Act of 2005, which provides for NRC regulation of accelerator-
produced radioactive material and discrete sources of Ra-226; (2) 
Status of Specialty Board applications for NRC recognition; (3) 
Electronic signature in written directives; (4) Revision of NRC Form 
313A; (5) RIS on dose control and assessment; (6) Review of the medical 
events definition commission paper. To review the agenda, see http://
www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact, via e-
mail MSS@nrc.gov.
    Purpose: Discuss issues related to 10 CFR part 35, Medical Use of 
Byproduct Material.
    Date and Time for Closed Session Meeting: October 25, 2005, from 8 
a.m. to 10 a.m. This session will be closed so that NRC staff can brief 
the ACMUI on discussing information relating solely to internal 
personnel rules.
    Dates and Times for Public Meetings: October 25, 2005, from 10 a.m. 
to 5 p.m.; and October 26, 2005, from 8 a.m. to 5 p.m.
    Address for Public Meetings: U.S. Nuclear Regulatory Commission, 
Two White Flint North Building, Room T2B3, 11545 Rockville Pike, 
Rockville, MD 20852-2738.

FOR FURTHER INFORMATION CONTACT: Mohammad S. Saba, telephone (301) 415-
7608; e-mail MSS@nrc.gov of the Office of Nuclear Material Safety and 
Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Mohammad S. Saba, U.S. Nuclear Regulatory 
Commission, Mail Stop T8F03, Washington, DC 20555. Submittals must be 
postmarked by October 3, 2005 and must pertain to the topics on the 
agenda for the meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (http://www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about January 26, 2006. This meeting 
will be held in accordance with the Atomic Energy Act of 1954, as 
amended (primarily Section 161a); the Federal Advisory Committee Act (5 
U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of 
Federal Regulations, Part 7.
    4. Attendees are requested to notify Mohammad S. Saba at (301) 415-
7608 of their planned attendance if special services, such as for the 
hearing impaired, are necessary.

    Dated at Rockville, Maryland, this 14th day of September, 2005.
    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05-18652 Filed 9-19-05; 8:45 am]
BILLING CODE 7590-01-P